By Keith L. Carson
Volume 12, Issue 1 (Spring 2013)
Consistent with our well-established format, this issue contains a very interesting collection of technical articles. However, we have stepped outside our normal content with a manuscript on the successful implementation of a “spin-out” company that was formed to develop a highly specialized technology. I’m hoping that this article by Dr. Charlotte Dyring (ExpreS2ion Biotechnologies) will provide inspiration to others who have envisioned a similar business model, plus trace a roadmap for organizations which have discovered that mergers and acquisitions aren’t giving them the products or sustainable growth they really need…
Citation: Carson KL. From the Editor-in-Chief: The Beneficial “Spin-Out” Business Model. BioProcess J, 2013; 12(1): 3. https://doi.org/10.12665/J121.Carson
Posted online July 21, 2026